Equity
At Evotec we are investing in bold ideas together with our partners. Through access to our cutting-edge highly innovative platforms, technologies, and our outstanding drug discovery expertise, we enable our Newcos to realize their bold ideas with the goal of developing medicines that matter to transform the lives of patients.
Our Approach
Since 2016 Evotec Ventures has invested over € 150 m in breakthrough innovation. We are pushing the boundaries of drug discovery and development to create breakthrough medicines.
We focus our investments on building early-stage pioneering biotechnology companies. Evotec Ventures provides not only seed stage funding, but also operational and strategic support empowering companies to accelerate their innovation potential.
We build longstanding relationships with our venture partners and leading entrepreneurs to create paradigm changing biotechnology companies.
Meet Our Partners
We invest in areas of high unmet medical need including oncology, metabolic diseases, neuroscience and public health. Our portfolio consists of 23 active investments.
